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During the SARS-CoV-2 outbreak, Italy was the leading
country for the number of new positive cases from
March 8 2020, to March 21, and the first for the total
number of deaths from March 19, to April 12 2020 [1–
4]. The Italian National Healthcare System required the
conversion of many wards into COVID-19 care units,
and the suspension of deferrable treatments, surgical
procedures and outpatient visits, to dedicate human and
material resources to free Intensive Care Unit (ICU)
beds. In the most struck regions, some hospitals were
designated as hubs for non-delayable treatments [5, 6].
Our institution (IRCCS Orthopaedic Institute Galeazzi)
was chosen amongst the Trauma Hubs.
Orthopaedic trauma surgery focused mainly on femoral
fragility fractures in the elderly, since the “lockdown”
began on March 10, 2020. Proximal femur fractures carry
a high mortality rate [7], and the standard of care involves
surgery within 48 h from the trauma [8]. These elderly pa-
tients are also the most susceptible to the nefarious conse-
quences of COVID-19 [9]. Thus, orthopaedic surgeons
face the daily dilemma of performing life-saving surgery
on patients who, given their severe respiratory comprom-
ise, have a higher risk of peri-operative death. Preliminary
reports from Wuhan, Bergamo (the Italian province with
the highest number of cases) and Spain drew different
conclusions on the possible benefit effects of surgery on
COVID-19 patients with proximal femur fractures [10–
12]. In the first case series, six patients reported proximal
femur fractures, but only three were considered eligible
for surgery because of no signs of pneumonia at CT scan
or non-severe respiratory symptoms [10]. Three of them
died, two after conservative management. Of the three
surviving patients, two underwent surgery: the authors
concluded that patients with proximal femoral fractures
and COVID-19 have a higher risk of death. In a series of
16 such patients in Bergamo (Lombardy), Italy [11], three
patients died before surgeries for respiratory failure. The
other 13 patients (temperature < 38 °C, pO2 > 90% and no
signs of multiorgan dysfunction) underwent surgery, with
four dying in the first postoperative week. Oxygen satur-
ation improved after surgery in the survivors. Finally, a
multicentre observational study on 136 proximal femoral
fractures reported an overall 30.4% mortality in COVID-
19 patients. The mortality rate was 67% in COVID-19 pa-
tients treated non-operatively, and only 4% in patients
who underwent surgery [12].
The early outcomes (March 17–April 17, 2020) from
our Trauma hub endorse the “to fix” faction. Ten swab-
confirmed COVID-19 patients (8 women and 2 men) with
a mean age of 83.9 ± 7.4 years (range 72-98) underwent
surgical treatment for their proximal femoral fractures
within 48 h from admission at our facility: 8 patients re-
ceived intramedullary nailing for AO 31A fractures, and 2
received hemiarthroplasty for AO 31B fractures [13]. The
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mean oxygen saturation on admission was 94.4% (range
90-97), breathing ambient air by 9 patients and 4 litres/
minute oxygen through Venturi mask by 1 patient. In 6
patients, atypical pneumonia was evident on plain chest
radiographs on admission. Three patients underwent a
further plain chest radiograph after surgery (one showed
improvement, one a stable pulmonary involvement and in
one patient the pneumonia worsened). Four patients de-
veloped systemic complications, including respiratory fail-
ure as reported in Table 1. Only two of these patients
died, both 8 days after surgery: one of them had pneumo-
nia on plain chest radiographs on admission. Both these
patients presented the lowest oxygen saturation breathing
ambient air on admission (93% and 90%, respectively).
The mean length of stay in the Trauma Unit was 12.9 ±
6.9 days (range 7-29), and the surviving patients were fi-
nally discharged to our in-hospital rehabilitation unit with
an improved or stable oxygen saturation, with 7 of the 8
surviving patients needing no further oxygen support.
Our patients exhibited the lowest death rate (20%) to
date, but, given the heterogeneous data reported by the
other two case series, and the missing individual patient
data of the multicentric study, the reasons for this
favourable finding are unclear. In our centre, surgery for
proximal femur fractures in the elderly is performed
within 48 h from admission in more than 95% of pa-
tients, and this was the case for all COVID-19 patients.
Two of the three operated patients reported by Mi et al.
received surgery 5, 2 and 3 days after admission [10].
Catellani et al. reported surgery within 24 h after admis-
sion for 10 patients, whilst in three cases, it was post-
poned for haemorrhagic risk as the patients were using
anticoagulant drugs [11]. Muñoz-Vives reported a mean
delay from admission to surgery of 2.4 days (range 0-13)
[12]. Secondly, an internal protocol, based on the previ-
ously published evidence of microvascular pulmonary
thrombosis in patients with COVID-19, established the
administration of low molecular weight heparin, doub-
ling the prophylactic dose (enoxaparin sodium 4000 U.I.
twice daily), as the nasopharyngeal swab showed positiv-
ity for SARS-CoV-2 [14]. The thromboembolic prophy-
lactic therapy, if administered, was not reported by Mi
and Muñoz-Vives, whilst Catellani et al. do not specify
the dosage they used [10–12]. Finally, the presence of
different SARS-CoV-2 clusters may explain the differ-
ences with the Chinese and Spanish studies, but it is un-
likely that the viral type differed between Milan and
Bergamo, two cities 60 km apart [15].
Furthermore, we retrospectively analysed the evolution
of their laboratory parameters at admission, 1st and 5th
± 2 postoperative days (POD1 and POD 5 ± 2) perform-
ing a univariate repeated measures ANOVA with
Greenhouse-Geisser correction and post hoc tests using
the Bonferroni adjustment (statistical significance set at
p ≤ 0.05; F statistic reported as F(degrees of freedomtime,
degrees of freedomerror) = F value, p value). Single-
patients laboratory parameters are available online as
Additional file 1. Our patients demonstrated a significant
reduction in leukocyte and neutrophils count and an in-
crease in lymphocyte relative count (Table 2) comparing
POD1 and POD 5 ± 2, possibly explained by the time
from surgery and by the COVID-19 infection resolution,
with an improvement of the peculiar SARS-CoV-2-re-
lated lymphopenia [16]. This is a noteworthy finding,
considering that a low lymphocyte percentage has been
considered a negative prognostic factor for COVID-19
[17].
The beneficial effects of early standard surgical care
for proximal femoral fractures in the elderly seem to be
confirmed also in COVID-19 patients. In-hospital man-
agement of fracture-related and cytokine-induced mus-
culoskeletal pain in COVID-19 patients should take into
account the recent warnings about the use of common
NSAIDs in case of SARS-CoV-2 infection [18–20].
Nevertheless, the mortality after proximal femur frac-
tures remains high, especially during the first year after
the fracture, and COVID-19 needs a very long time for
viral clearance [21, 22]. The contribution of surgery to
improve respiratory and laboratory values in COVID-19
patients with femur fractures should be verified by fur-
ther studies with a longer follow-up and with control
groups.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13018-020-01800-9.
Additional file 1. Laboratory values during hospitalization.
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